Citizens Business Bank second quarter net income down from 2015
CVB Financial Corp. and its subsidiary Citizens Business Bank reported $25.5 million net income for the second quarter of 2016, or 23 cents per share. That was down from $26.8 million for the second quarter of 2015, or 25 cents per share. Citizens Business Bank completed the integration of County Commerce Bank in the second Read More →
FDA declines to approve Novartis biosimilar for Amgen’s Neulasta
The Food and Drug Administration has declined for now to approve a copycat version of Amgen’s blockbuster drug Neulasta. Reuters reported July 19 that the FDA sent a letter to Swiss pharmaceutical Novartis at the end of June saying it was declining to approve the drug for now. Neulasta, made by Thousand Oaks-based biotech giant Read More →
Lockheed Martin second quarter earnings beat analyst estimates
Lockheed Martin revenues increased slightly and the company beat analyst estimates when it reported second quarter earnings results July 19. Lockheed Martin said sales increased during the quarter from $11.6 billion during the same quarter in 2015 to $12.9 billion in 2016. Earnings per share increased from $2.94 to $3.32 per share over the same Read More →
Goleta’s InTouch Health picks DeVivo to replace Wang as CEO
Goleta-based telemedicine provider InTouch Health appointed Joseph DeVivo as the new CEO to replace former CEO Dr. Yulun Wang, the company announced July 19. DeVivo was most recently the CEO of New York-based AngioDynamics, a publicly traded medical device manufacturer. He has more than 25 years of experience in the health care industry. “InTouch Health Read More →
Ceres third-quarter revenue up, losses down
Thousand Oaks-based ag-biotech company Ceres Inc. released third quarter results in documents filed with the Securities and Exchange Commission July 15. Ceres said revenues increased from $1.1 million during the third quarter of 2015 to $1.4 million during the third quarter of 2016. Net losses decreased from $5.9 million, or 98 cents per share, last Read More →